Report cover image

DNA/RNA Quality Control Industry Research Report 2025

Publisher APO Research, Inc.
Published Jul 06, 2025
Length 122 Pages
SKU # APRC20261096

Description

Summary

According to APO Research, The global DNA/RNA Quality Control market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for DNA/RNA Quality Control is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for DNA/RNA Quality Control is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for DNA/RNA Quality Control is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of DNA/RNA Quality Control include BigOmics Analytics, Cambridge Genomic Services, Creative Biogene, Eurofins Genomics, Genomics, Hokkaido System Science, LC Sciences, Life Magnetics and Norgen Biotek, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DNA/RNA Quality Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA/RNA Quality Control.

The DNA/RNA Quality Control market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DNA/RNA Quality Control market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

DNA/RNA Quality Control Segment by Company

BigOmics Analytics
Cambridge Genomic Services
Creative Biogene
Eurofins Genomics
Genomics
Hokkaido System Science
LC Sciences
Life Magnetics
Norgen Biotek
Omega Bioservices
PathoQuest
QIAGEN
QIMA Life Sciences
Thermo Fisher Scientific
DNA/RNA Quality Control Segment by Type

DNA Quality Control
RNA Quality Control
DNA/RNA Quality Control Segment by Application

Medical Diagnostics
Biological Research
Genomics
DNA/RNA Quality Control Segment by Application

Medical Diagnostics
Biological Research
Genomics
DNA/RNA Quality Control Segment by Region


North America
United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East & Africa

Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA/RNA Quality Control market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA/RNA Quality Control and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA/RNA Quality Control.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of DNA/RNA Quality Control companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

122 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 DNA/RNA Quality Control by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 DNA Quality Control
2.2.3 RNA Quality Control
2.3 DNA/RNA Quality Control by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Medical Diagnostics
2.3.3 Biological Research
2.3.4 Genomics
2.4 Assumptions and Limitations
3 DNA/RNA Quality Control Breakdown Data by Type
3.1 Global DNA/RNA Quality Control Historic Market Size by Type (2020-2025)
3.2 Global DNA/RNA Quality Control Forecasted Market Size by Type (2026-2031)
4 DNA/RNA Quality Control Breakdown Data by Application
4.1 Global DNA/RNA Quality Control Historic Market Size by Application (2020-2025)
4.2 Global DNA/RNA Quality Control Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global DNA/RNA Quality Control Market Perspective (2020-2031)
5.2 Global DNA/RNA Quality Control Growth Trends by Region
5.2.1 Global DNA/RNA Quality Control Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 DNA/RNA Quality Control Historic Market Size by Region (2020-2025)
5.2.3 DNA/RNA Quality Control Forecasted Market Size by Region (2026-2031)
5.3 DNA/RNA Quality Control Market Dynamics
5.3.1 DNA/RNA Quality Control Industry Trends
5.3.2 DNA/RNA Quality Control Market Drivers
5.3.3 DNA/RNA Quality Control Market Challenges
5.3.4 DNA/RNA Quality Control Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top DNA/RNA Quality Control Players by Revenue
6.1.1 Global Top DNA/RNA Quality Control Players by Revenue (2020-2025)
6.1.2 Global DNA/RNA Quality Control Revenue Market Share by Players (2020-2025)
6.2 Global DNA/RNA Quality Control Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of DNA/RNA Quality Control Head Office and Area Served
6.4 Global DNA/RNA Quality Control Players, Product Type & Application
6.5 Global DNA/RNA Quality Control Manufacturers Established Date
6.6 Global DNA/RNA Quality Control Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America DNA/RNA Quality Control Market Size (2020-2031)
7.2 North America DNA/RNA Quality Control Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America DNA/RNA Quality Control Market Size by Country (2020-2025)
7.4 North America DNA/RNA Quality Control Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe DNA/RNA Quality Control Market Size (2020-2031)
8.2 Europe DNA/RNA Quality Control Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe DNA/RNA Quality Control Market Size by Country (2020-2025)
8.4 Europe DNA/RNA Quality Control Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific DNA/RNA Quality Control Market Size (2020-2031)
9.2 Asia-Pacific DNA/RNA Quality Control Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific DNA/RNA Quality Control Market Size by Country (2020-2025)
9.4 Asia-Pacific DNA/RNA Quality Control Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America DNA/RNA Quality Control Market Size (2020-2031)
10.2 South America DNA/RNA Quality Control Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America DNA/RNA Quality Control Market Size by Country (2020-2025)
10.4 South America DNA/RNA Quality Control Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa DNA/RNA Quality Control Market Size (2020-2031)
11.2 Middle East & Africa DNA/RNA Quality Control Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa DNA/RNA Quality Control Market Size by Country (2020-2025)
11.4 Middle East & Africa DNA/RNA Quality Control Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 BigOmics Analytics
12.1.1 BigOmics Analytics Company Information
12.1.2 BigOmics Analytics Business Overview
12.1.3 BigOmics Analytics Revenue in DNA/RNA Quality Control Business (2020-2025)
12.1.4 BigOmics Analytics DNA/RNA Quality Control Product Portfolio
12.1.5 BigOmics Analytics Recent Developments
12.2 Cambridge Genomic Services
12.2.1 Cambridge Genomic Services Company Information
12.2.2 Cambridge Genomic Services Business Overview
12.2.3 Cambridge Genomic Services Revenue in DNA/RNA Quality Control Business (2020-2025)
12.2.4 Cambridge Genomic Services DNA/RNA Quality Control Product Portfolio
12.2.5 Cambridge Genomic Services Recent Developments
12.3 Creative Biogene
12.3.1 Creative Biogene Company Information
12.3.2 Creative Biogene Business Overview
12.3.3 Creative Biogene Revenue in DNA/RNA Quality Control Business (2020-2025)
12.3.4 Creative Biogene DNA/RNA Quality Control Product Portfolio
12.3.5 Creative Biogene Recent Developments
12.4 Eurofins Genomics
12.4.1 Eurofins Genomics Company Information
12.4.2 Eurofins Genomics Business Overview
12.4.3 Eurofins Genomics Revenue in DNA/RNA Quality Control Business (2020-2025)
12.4.4 Eurofins Genomics DNA/RNA Quality Control Product Portfolio
12.4.5 Eurofins Genomics Recent Developments
12.5 Genomics
12.5.1 Genomics Company Information
12.5.2 Genomics Business Overview
12.5.3 Genomics Revenue in DNA/RNA Quality Control Business (2020-2025)
12.5.4 Genomics DNA/RNA Quality Control Product Portfolio
12.5.5 Genomics Recent Developments
12.6 Hokkaido System Science
12.6.1 Hokkaido System Science Company Information
12.6.2 Hokkaido System Science Business Overview
12.6.3 Hokkaido System Science Revenue in DNA/RNA Quality Control Business (2020-2025)
12.6.4 Hokkaido System Science DNA/RNA Quality Control Product Portfolio
12.6.5 Hokkaido System Science Recent Developments
12.7 LC Sciences
12.7.1 LC Sciences Company Information
12.7.2 LC Sciences Business Overview
12.7.3 LC Sciences Revenue in DNA/RNA Quality Control Business (2020-2025)
12.7.4 LC Sciences DNA/RNA Quality Control Product Portfolio
12.7.5 LC Sciences Recent Developments
12.8 Life Magnetics
12.8.1 Life Magnetics Company Information
12.8.2 Life Magnetics Business Overview
12.8.3 Life Magnetics Revenue in DNA/RNA Quality Control Business (2020-2025)
12.8.4 Life Magnetics DNA/RNA Quality Control Product Portfolio
12.8.5 Life Magnetics Recent Developments
12.9 Norgen Biotek
12.9.1 Norgen Biotek Company Information
12.9.2 Norgen Biotek Business Overview
12.9.3 Norgen Biotek Revenue in DNA/RNA Quality Control Business (2020-2025)
12.9.4 Norgen Biotek DNA/RNA Quality Control Product Portfolio
12.9.5 Norgen Biotek Recent Developments
12.10 Omega Bioservices
12.10.1 Omega Bioservices Company Information
12.10.2 Omega Bioservices Business Overview
12.10.3 Omega Bioservices Revenue in DNA/RNA Quality Control Business (2020-2025)
12.10.4 Omega Bioservices DNA/RNA Quality Control Product Portfolio
12.10.5 Omega Bioservices Recent Developments
12.11 PathoQuest
12.11.1 PathoQuest Company Information
12.11.2 PathoQuest Business Overview
12.11.3 PathoQuest Revenue in DNA/RNA Quality Control Business (2020-2025)
12.11.4 PathoQuest DNA/RNA Quality Control Product Portfolio
12.11.5 PathoQuest Recent Developments
12.12 QIAGEN
12.12.1 QIAGEN Company Information
12.12.2 QIAGEN Business Overview
12.12.3 QIAGEN Revenue in DNA/RNA Quality Control Business (2020-2025)
12.12.4 QIAGEN DNA/RNA Quality Control Product Portfolio
12.12.5 QIAGEN Recent Developments
12.13 QIMA Life Sciences
12.13.1 QIMA Life Sciences Company Information
12.13.2 QIMA Life Sciences Business Overview
12.13.3 QIMA Life Sciences Revenue in DNA/RNA Quality Control Business (2020-2025)
12.13.4 QIMA Life Sciences DNA/RNA Quality Control Product Portfolio
12.13.5 QIMA Life Sciences Recent Developments
12.14 Thermo Fisher Scientific
12.14.1 Thermo Fisher Scientific Company Information
12.14.2 Thermo Fisher Scientific Business Overview
12.14.3 Thermo Fisher Scientific Revenue in DNA/RNA Quality Control Business (2020-2025)
12.14.4 Thermo Fisher Scientific DNA/RNA Quality Control Product Portfolio
12.14.5 Thermo Fisher Scientific Recent Developments
13 Report Conclusion
14 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.